Adverse Effects: Tendinopathy and Phototoxicity

Beyond the adverse effects shared by many antibacterials, fluoroquinolones carry two characteristic class-effect toxicities that have shaped how the class is viewed: tendinopathy, including a risk of tendon rupture, and phototoxicity, an exaggerated sunburn-like skin reaction on sun-exposed areas. Both have prompted regulatory safety warnings and are central to the class's risk profile.

Definition

Fluoroquinolone class-effect adverse effects are toxicities observed across the class rather than tied to a single agent; the two emphasized here are tendinopathy (tendon pain, inflammation, and risk of rupture, classically of the Achilles tendon) and phototoxicity (a photochemically mediated, sunburn-like skin reaction).

Scope

The entry summarizes the two best-recognized class-characteristic fluoroquinolone toxicities — tendinopathy/tendon rupture and phototoxicity — together with brief mention of other class-effect concerns (QT-interval effects, peripheral neuropathy, dysglycaemia, CNS effects). It is a reference-educational account of toxicology and does not give dosing, monitoring, or treatment instructions.

Core questions

• Why are fluoroquinolone toxicities described as 'class effects'?
• What is the proposed basis of fluoroquinolone-associated tendinopathy and which patients appear more susceptible?
• What distinguishes phototoxicity from photoallergy, and how does fluoroquinolone structure relate to phototoxic potential?
• What other class-characteristic adverse effects round out the safety profile?

Key concepts

• Class-effect adverse events
• Tendinopathy and Achilles tendon rupture
• Phototoxicity (photochemical skin reaction)
• Photoallergy versus phototoxicity
• Risk factors (older age, corticosteroid co-use)
• QT-interval prolongation
• Peripheral neuropathy and CNS effects

Mechanisms

Fluoroquinolone-associated tendinopathy is thought to involve drug effects on tendon extracellular matrix and tenocytes — including disturbances of collagen and matrix metabolism and possible chelation of matrix-associated metal ions — producing degenerative changes that can predispose to rupture, classically of the Achilles tendon; risk appears greater with older age and concurrent corticosteroid use (Duman et al., 2025; Owens & Ambrose, 2005). Phototoxicity is a photochemical, non-immunologic reaction: ultraviolet light excites the absorbed drug in the skin, generating reactive species that damage cells and produce an exaggerated sunburn-like response, and the magnitude varies with the specific fluoroquinolone's structure (Traynor & Gibbs, 2000; Ferguson, 2000). The class is additionally associated with QT-interval prolongation, peripheral neuropathy, dysglycaemia, and central nervous system effects, the relative prominence of which differs among individual agents (Owens & Ambrose, 2005).

Clinical relevance

Recognizing these class-characteristic toxicities is central to appraising the benefit-risk balance of fluoroquinolones and to understanding regulatory safety communications about the class. This entry describes the nature and proposed mechanisms of the adverse effects for educational and appraisal purposes; it is not monitoring, diagnostic, or treatment guidance for any individual.

Epidemiology

Tendon disorders are an uncommon but well-documented fluoroquinolone-associated event, with the Achilles tendon most often implicated and risk concentrated in older adults and those taking corticosteroids; phototoxic skin reactions vary in frequency across individual agents according to their photochemical properties (Owens & Ambrose, 2005; Duman et al., 2025; Ferguson, 2000).

Evidence & guidelines

The class-safety picture is drawn from pharmacovigilance and safety reviews (Owens & Ambrose, 2005), a recent review of tendinopathy and tendon rupture (Duman et al., 2025), and phototoxicity studies and reviews comparing agents (Traynor & Gibbs, 2000; Ferguson, 2000). Multiple regulators have issued class-wide fluoroquinolone safety warnings; their current text should be consulted directly rather than paraphrased here.

History

Reports of fluoroquinolone-associated tendon injury and phototoxicity accumulated through the 1980s and 1990s as the class came into wide use, and differences among agents in phototoxic potential influenced which compounds advanced. The body of evidence eventually led drug regulators to add prominent class-wide warnings about disabling and potentially irreversible adverse effects, repositioning the class in therapy.

Debates

How should the benefit-risk balance of fluoroquinolones be framed given class-effect toxicities?

Because some adverse effects can be disabling or long-lasting, there is ongoing discussion about reserving fluoroquinolones when comparably effective alternatives exist, weighed against their efficacy and convenience; this is a regulatory and stewardship judgement rather than a settled mechanistic point.

Key figures

• Robert C. Owens
• James Ferguson
• Neil K. Gibbs

Seminal works

• owens-ambrose-2005

Frequently asked questions

Which tendon is most commonly affected by fluoroquinolone-associated tendinopathy?

The Achilles tendon is most frequently implicated. The risk is higher in older adults and in people taking corticosteroids, though tendon injury overall is an uncommon event.

What is the difference between phototoxicity and photoallergy?

Phototoxicity is a non-immune, photochemical reaction in which light-activated drug in the skin directly damages cells, producing an exaggerated sunburn-like response; photoallergy is an immune-mediated reaction. Fluoroquinolone skin reactions are chiefly phototoxic.